An ins(X;11)(q24;q23) fuses the MLL and the septin 6/KIAA0128 gene in an infant with AML-M2

被引:43
作者
Borkhardt, A
Teigler-Schlegel, A
Fuchs, U
Keller, C
König, M
Harbott, J
Haas, OA
机构
[1] Univ Giessen, Dept Pediat Hematol & Oncol, Giessen, Germany
[2] St Anna Childrens Hosp, Ludwig Boltzmann Inst Cytogenet Diag, Vienna, Austria
[3] St Anna Childrens Hosp, Childrens Canc Res Inst, Vienna, Austria
关键词
D O I
10.1002/gcc.1169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The MLL (HRX, ALL-I HTRX) gene at chromosome band 11q23 frequently is rearranged in acute lymphoblastic and myeloblastic leukemia. To date, more than 40 different 11q23 abnormalities have been described on the cytogenetic level, and at least 25 of the respective fusion partner genes are cloned. The vast majority of the respective reciprocal translocations generate a chimeric 5'-MLL/partner-3' gene on the derivative 11q23. In this work, we report a unique ins(X;11)(q24;q23) in an infant with acute myeloid leukemia (AML-M2) that fuses the human KIAA0128 gene at Xq24 with MLL. In contrast to the typical reciprocal MLL translocations, however, we provide evidence that the 5'-MLL/KIAA0128-3' fusion resides on Xq24 rather than on I I q23. The KIAA0128 gene encodes the human Septin 6 protein, which contains an ATP-GTP binding motif and three nuclear targeting sequences in its carboxy terminus. The maintenance of the reading frame of the 5'-MLL/KIAA0128-3' mRNA fusion allows for the formation of a novel chimeric protein. Septin 6 is the third member of the Septins that is fused to the MILL protein; the other two are hCDCrel at 22q11 and MSF at 17q25. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 45 条
  • [1] Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age
    Behm, FG
    Raimondi, SC
    Frestedt, JL
    Liu, Q
    Crist, WM
    Downing, JR
    Rivera, GK
    Kersey, JH
    Pui, CH
    [J]. BLOOD, 1996, 87 (07) : 2870 - 2877
  • [2] The septin CDCrel-1 binds syntaxin and inhibits exocytosis
    Beites, CL
    Xie, H
    Bowser, R
    Trimble, WS
    [J]. NATURE NEUROSCIENCE, 1999, 2 (05) : 434 - 439
  • [3] MOLECULAR-BASIS OF 11Q23 REARRANGEMENTS IN HEMATOPOIETIC MALIGNANT PROLIFERATIONS
    BERNARD, OA
    BERGER, R
    [J]. GENES CHROMOSOMES & CANCER, 1995, 13 (02) : 75 - 85
  • [4] Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23)
    Borkhardt, A
    Repp, R
    Haas, OA
    Leis, T
    Harbott, J
    Kreuder, J
    Hammermann, J
    Henn, T
    Lampert, F
    [J]. ONCOGENE, 1997, 14 (02) : 195 - 202
  • [5] BORKHARDT A, 1994, LEUKEMIA, V8, P549
  • [6] Localization of a novel septin protein, hCDCrel-1, in neurons of human brain
    Caltagarone, J
    Rhodes, J
    Honer, WG
    Bowser, R
    [J]. NEUROREPORT, 1998, 9 (12) : 2907 - 2912
  • [7] ACUTE LEUKEMIAS OF DIFFERENT LINEAGES HAVE SIMILAR MLL GENE FUSIONS ENCODING RELATED CHIMERIC PROTEINS RESULTING FROM CHROMOSOMAL TRANSLOCATION
    CORRAL, J
    FORSTER, A
    THOMPSON, S
    LAMPERT, F
    KANEKO, Y
    SLATER, R
    KROES, WG
    VANDERSCHOOT, CE
    LUDWIG, WD
    KARPAS, A
    POCOCK, C
    COTTER, F
    RABBITTS, TH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8538 - 8542
  • [8] An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes
    Corral, J
    Lavenir, I
    Impey, H
    Warren, AJ
    Forster, A
    Larson, TA
    Bell, S
    McKenzie, ANJ
    King, G
    Rabbitts, TH
    [J]. CELL, 1996, 85 (06) : 853 - 861
  • [9] Association of SET domain and myotubularin-related proteins modulates growth control
    Cui, XM
    De Vivo, I
    Slany, R
    Miyamoto, A
    Firestein, R
    Cleary, ML
    [J]. NATURE GENETICS, 1998, 18 (04) : 331 - 337
  • [10] MLL rearrangements in haematological malignancies: Lessons from clinical and biological studies
    DiMartino, JF
    Cleary, ML
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 614 - 626